Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Colorectal Neoplasms 6Neoplasm Metastasis 4Colonic Neoplasms 4Rectal Neoplasms 3Stomach Neoplasms 2Peritoneal Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Gallbladder Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Disease Progression 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Bile Duct Neoplasms 1

Interventions

Trastuzumab 77Capecitabine 59Cyclophosphamide 54Paclitaxel 51Docetaxel 49Letrozole 44Fulvestrant 43Lapatinib 34Doxorubicin 31Carboplatin 31Vinorelbine 30Bevacizumab 29Anastrozole 28pembrolizumab 25exemestane 24Tamoxifen 23Gemcitabine 22Radiotherapy 21Albumin-Bound Paclitaxel 19Everolimus 17Taxes 16Epirubicin 15Ado-Trastuzumab Emtansine 13130-nm albumin-bound paclitaxel 13pertuzumab 12palbociclib 12liposomal doxorubicin 11Magnetic Resonance Spectroscopy 11Filgrastim 11Cisplatin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Breast Neoplasms × Folfox protocol × Clear all
NCT01937507 2018-02-07

Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer

Western Regional Medical Center

Phase 2 Terminated
2 enrolled 1 chart
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡